(Q50890478)

English

Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism.

scientific article published on 18 October 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

0 references

Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

steatohepatitis

0 references

author name string

Pablo Quintero

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

Marco Arrese

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

language of work or name

0 references

publication date

18 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

58

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

1881-1884

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Epidemiology and natural history of patients with NAFLD.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Evolving aspects of liver transplantation for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

An overview on biological mechanisms of PPARs.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

PPARs at the crossroads of lipid signaling and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Examining the safety of PPAR agonists - current trends and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Peroxisome proliferator-activated receptor δ: a multifaceted metabolic player

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

21 January 2018

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26582

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26582

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23787705

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50890478&oldid=1458821696"